Cytek Biosciences Inc
General ticker "CTKB" information:
- Sector: Health Care
- Industry: Life Sciences Tools & Services
- Capitalization: $855.1M
Cytek Biosciences Inc does not follow the US Stock Market performance with the rate: -12.6%.
Estimated limits based on current volatility of 3.3%: low 6.07$, high 6.49$
Factors to consider:
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [4.53$, 9.06$]
- 2024-12-30 to 2025-12-30 estimated range: [4.38$, 8.68$]
Financial Metrics affecting the CTKB estimates:
- Negative: Non-GAAP EPS, $ of 0.06 <= 0.10
- Negative: Operating profit margin, % of -12.61 <= 1.03
- Negative: Operating cash flow per share per price, % of 0.48 <= 2.35
- Negative: Industry operating cash flow per share per price (median), % of 0.50 <= 3.85
- Positive: -0.96 < Investing cash flow per share, $ of -0.69
- Positive: Interest expense per share, $ of 0.02 <= 0.14
Short-term CTKB quotes
Long-term CTKB plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $127.95MM | $164.04MM | $193.01MM |
| Operating Expenses | $118.79MM | $165.84MM | $220.86MM |
| Operating Income | $9.16MM | $-1.80MM | $-27.84MM |
| Non-Operating Income | $-3.22MM | $3.06MM | $12.14MM |
| Interest Expense | $1.74MM | $2.57MM | $2.07MM |
| R&D Expense | $24.44MM | $34.86MM | $44.15MM |
| Income(Loss) | $5.94MM | $1.26MM | $-15.71MM |
| Taxes | $2.91MM | $-1.22MM | $-3.56MM |
| Other Income(Loss) | $-0.03MM | $0.09MM | $0.00MM |
| Profit(Loss) | $3.00MM | $2.58MM | $-12.15MM |
| Stockholders Equity | $405.38MM | $425.55MM | $393.06MM |
| Inventory | $32.17MM | $48.15MM | $60.88MM |
| Assets | $463.31MM | $519.48MM | $494.46MM |
| Operating Cash Flow | $4.63MM | $-12.23MM | $5.28MM |
| Capital expenditure | $4.36MM | $9.87MM | $4.83MM |
| Investing Cash Flow | $-20.99MM | $-55.91MM | $-93.89MM |
| Financing Cash Flow | $213.56MM | $5.51MM | $-41.81MM |
| Earnings Per Share* | $0.03 | $0.02 | $-0.09 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.